Skip to main content
Fig. 1 | Immunity & Ageing

Fig. 1

From: Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial

Fig. 1

Randomization and Patient Flow in the Immunogenicity Study Comparing Trivalent Adjuvanted Inactivated Influenza Vaccine (aIIV3) vs. Trivalent High-Dose Inactivated Influenza Vaccine (HD-IIV3). The Full Analysis Population consisted of all participants who were randomized and vaccinated. The Immunogenicity Population consisted of all participants who were randomized, vaccinated and had a sufficient blood draw within the protocol defined time window

Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us